Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Replicel Life Sciences Inc
V.RP
Alternate Symbol(s):
REPCF
Technology
Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair...
restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Jun 27, 2022 3:36pm
RE:RE:RE:RE:RE:RE:This Week
I'm really not that hopeful, after all these years they've promised so much and delivered absolutely nothing, it's very disappointing!
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Jun 26, 2022 10:22pm
RE:RE:RE:RE:RE:This Week
Sry, not buy YOFOTO...but buy their stake
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Jun 26, 2022 10:22pm
RE:RE:RE:RE:This Week
Overall cautiously optimistic...we've been excited in the past. We all know how that's worked out. I also don't this Shiseido is interested in all of Replicel. They would then have
...more
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Jun 26, 2022 10:20pm
RE:RE:RE:This Week
Your third option seems less plausible- while Replicel may not have held up to their end of the agreement, they still own all of the global patents
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jun 26, 2022 7:38pm
RE:RE:This Week
I am definetley betting on good news. I am pretty sure tht the Shiseido Arbitration will go Relpicel's way. if so it could be very big for the company. This could play out in a
...more
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Jun 26, 2022 4:21pm
RE:This Week
What are you betting on... good news or bad news?
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jun 26, 2022 3:01pm
This Week
I think this will be an interesting week. The MCTO will be removed and that should hopefully free up management to update the market on the two most important issues facing Replicel: What is the
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jun 23, 2022 2:10pm
MCTO vs Private Placement
Replicel Insiders are presently under a MCTO until the 2021 financials are submitted no later than June 30th. Therefore they cannot participate in the extended Private Placement which closes on
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jun 23, 2022 12:20pm
A Few Buyers Today
Always encouraging to see a few buyers show up. Possibly there is some speculation that once the 2021 financials are submitted (deadline June 30th) and the MCTO is lifted we may see an update. &
...more
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Jun 21, 2022 11:43am
RE:RE:Private Placement
All of their patents must be worth a good chunck of change hoping for $5+
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jun 21, 2022 11:34am
RE:Private Placement
This is ripe for a hostel takeover ! I ment hostile (autocorrect).
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jun 21, 2022 11:31am
Private Placement
From Stockwatch June 7th: "On May 4, 2022, the company closed a first tranche of the offering pursuant to which it sold an aggregate of 4,218,470 units for gross proceeds of $759,324.60."
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jun 20, 2022 4:05pm
What's Next
This from Stockwatch June 15th RepliCel expects to file 2021 financials by June 30 RepliCel Life Sciences Inc. is providing a default status report in accordance with the alternative information
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jun 15, 2022 3:11pm
RE:Nice Replicel Twitter Update!
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income